HRT Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39,166
| Closed | -$761K | – | 3015 |
|
|
2023
Q2 | $761K | Sell |
39,166
-5,617
| -13% | -$109K | 0.01% | 1029 |
|
|
2023
Q1 | $1.27M | Sell |
44,783
-16,276
| -27% | -$462K | 0.02% | 780 |
|
|
2022
Q4 | $1.78M | Buy |
+61,059
| New | +$1.78M | 0.03% | 617 |
|
|
2022
Q3 | – | Sell |
-15,389
| Closed | -$683K | – | 3497 |
|
|
2022
Q2 | $683K | Buy |
15,389
+263
| +2% | +$11.7K | 0.01% | 1237 |
|
|
2022
Q1 | $748K | Sell |
15,126
-4,387
| -22% | -$217K | 0.01% | 1135 |
|
|
2021
Q4 | $993K | Buy |
19,513
+10,722
| +122% | +$546K | 0.01% | 1007 |
|
|
2021
Q3 | $490K | Buy |
+8,791
| New | +$490K | ﹤0.01% | 1819 |
|